Published in
Taylor and Francis Group, Leukemia & Lymphoma, 4(60), p. 912-919, 2018
DOI: 10.1080/10428194.2018.1515937
Links
Tools
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Journal article published in 2018 by
Tony Reiman,
Kerry J. Savage,
Michael Crump,
Matthew C. Cheung,
David MacDonald,
Rena Buckstein,
Stephen Couban,
Eugenia Piliotis,
Kevin Imrie,
David Spaner,
Sudeep Shivakumar,
John Kuruvilla,
Diego Villa 
,
Lois E. Shepherd,
Tanya Skamene
and other authors.
,
Lois E. Shepherd,
Tanya Skamene
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 